Do you hear what I’m saying, Macron? AstraZeneca provides ‘longer immunity,’ and there is no need for a booster shot.
ASTRAZENECA’s vaccine could potentially “provide extended immunity,” and booster shots may not be required for complete protection against the COVID-19 virus, according to the company’s CEO.
AstraZeneca’s CEO, Pascal Soriot, has stated that he expects more concrete results in the coming months proving that one vaccination dose is sufficient for full protection. Mr. Soriot’s firm is looking for data that shows the vaccination is producing a lot of “T cell immunity.” T cells are immune system white blood cells that provide a different sort of immunity than antibodies, and that immunity may remain longer.
Thousands of elderly and vulnerable people are scheduled to receive booster shots this autumn, with the NHS continuously concerned that vaccine protection may fade over time.
If data from the autumn shows that T cells are created, it’s possible that those who had the AstraZeneca vaccine won’t need the second.
“We hope that the Oxford-AstraZeneca deal will provide longer-term protection,” Mr Soriot told the Daily Mail.
“Based on what we’ve learned so far, our vaccine induces a robust T cell response, which I hope indicates its effects will endure longer.
“So, that seems fantastic, but we don’t know if you’ll need a booster just yet. ‘Only time will tell.’
Mr. Soriot’s firm anticipates receiving the requisite data in October or November.
If the results are encouraging, the discoveries will be welcomed by the NHS, which is under pressure to administer millions of urgent booster doses before winter arrives.
According to a study conducted by Birmingham University, the AstraZeneca vaccine activates T cells that fight illness more than Pfizer and Moderna’s American counterparts.
Mr Soriot further stated that data collected by Johnson & Johnson, a pharma company that uses the same vaccine technology as AstraZeneca, demonstrates that the Covid vaccination ‘provides years of protection.’
The Oxford-AstraZeneca vaccine is particularly efficient against the rampaging Delta strain, according to authoritative data, according to the CEO.
The news came after a prominent economist accused Emmanuel Macron of attempting to “undermine confidence” in the AstraZeneca vaccine.
Economist Julian Jessop wrote in the Daily Telegraph that Brussels deserved “a lot of stick.” “Brinkwire News in Condensed Form.”